Accelerate to discover

Back to filter

Related topics

ACCELA Educational webinar series: Unlocking Spatial Biology with RareCyte Orion Technology

RareCyte

Nov 16, 2022

Discover full slide, high-plex biomarker quantitation with the all-in-one spatial biology...

Practical aspects of an imaging study: live in vivo scanning

MOLECUBES

Nov 11, 2022

In this webinar, MOLECUBES will present a live in vivo demonstration, showing the entire workflow from animal...

All inside your incubator: xCELLigence eSight

Agilent technologies

Nov 3, 2022

Multiplex Live cell imaging and real-time biosensor measurement with xCELLigence eSight

Download the newest AVATAR data presented at CAR-TCR

Xcell Biosciences

Oct 21, 2022

Xcell Bio CSO, James Lim, presented new data showcasing improved potency of AVATAR-expanded CAR T cells and highlighted...

Nov 27, 2022

RareCyte Orion system advances Multi-modal digital pathology for colorectal cancer diagnosis

RareCyte

Oct 19, 2022

Precision medicine is critically dependent on better methods for diagnosing and staging disease and predicting drug...

Introducing MARS system : revolutionary solution for your workflow of cell separation and enrichment

Applied Cells

Oct 7, 2022

The MARS family of instruments provides a breakthrough solution to complete the workflow of cell separation and...

AMI HTX installation in CEMEX Iasi, Romania

Spectral Instruments Imaging

Sep 30, 2022

Presentation movie

Nov 27, 2022

Introducing RareCyte Orion, integrating Spatial Biology with Multiplex Imaging

RareCyte

Sep 13, 2022

Orion, the highly multiplexed fluorescent imaging system, empower investigators to unlock spatial context for key...

Show all topics (10)

Duke uses XRAD 225 CX to test radiosensitivity hypothesis

Oct 18, 2021

Diffuse intrinsic pontine glioma (DIPG) kills more children than any other type of brain tumor. Despite clinical trials testing many chemotherapeutic agents, palliative radiotherapy remains the standard treatment. In this paper, tumor genotype dictates radiosensitization after ATM deletion in primary brainstem glioma models. While these tumors need more study, getting greater response rates with existing compounds is immediately translatable to the clinic. Here our friends at Duke, use XRAD 225 CX to test their hypothesis that greater radiosensitivity will lead to better response rates. Read it for yourself:

Do you want to learn more? Read the whole article or just ask us!

Scientific paper
Application

Related technologies: X-ray irradiation

Get more info

Miroslav Vecheta

Support specialist

Miroslav

Vecheta

+420 210 323 421

Send Message

Brand profile

Precision X-Ray

Precision X-ray is the leading provider of safe, high output X-Ray irradiators used in modern translational research. 

Related products

The benchtop system to irradiate cells in your lab without compromising sterility or security

show detail

The compact cabinet X-ray irradiator designed for superficial irradiation studies, and is ideal for delivering high doses to cell and tissue cultures

show detail

The series to provide better uniform penetration, the best suited for larger cell cultures and some small animal research applications

show detail

A series of compact, fully integrated x-ray irradiators that are simpler and safer alternatives to radioisotope irradiators.

show detail

The series is widely used around the world for small animal research and high dose cellular research

show detail

The unit provides deeper dose depth uniformity, allowing research on even larger biological specimens with increased dose rates

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey